Verified data · Analyst-authored · AI-accelerated Updated daily · sentiment rescored daily

Institutional-Grade
Biotech Intelligence

Real, industry-grade financial data — verified financials and ClinicalTrials.gov-checked pipelines — turned into institutional-grade research by human analysts, accelerated by AI. Built for serious European biotech investors, across 5,800+ US & EU tickers.

12–15-page institutional deep-dives
17–25 cited sources each
Free tier · no card
F2 · CAL Catalyst calendar Sample data
DateTickerEvent Forecast
MONQVLT PDUFA ▲ +12–18%
TUEZYRN CHMP ▲ +6–9%
WEDHXPR P3 READOUT ▼ −10–16%
THUATLB ADCOMM Forecast available on Pro PRO
FRINMBT 8-K ▲ +2–4%
HXPR · SENTIMENT
FIN 7.2 TEC 8.4 REG 5.1
Sample rows for illustration · the live calendar tracks 3,600+ upcoming catalysts
5,800+
Companies tracked · US & EU
3,600+
Upcoming catalysts tracked
14,750+
AI briefs generated
28
Institutional deep-dives live

Counts refresh from the platform catalog. Sources: FDA · EMA CHMP · EU CTIS · SEC EDGAR · ClinicalTrials.gov · FMP.

Real data, not guesswork Primary sources only

Industry-grade financial data.
Accelerated by AI, never hallucinated.

Every figure comes from audited, industry-standard sources and verified filings — never invented by a model. AI just helps us surface and structure it faster. Headlines are scored for momentum; they never become facts.

FDAPDUFA & AdComm dates
EMACHMP agendas
EU CTISTrial registrations
SEC EDGAR8-K events & Form 4 flow
ClinicalTrials.govPipeline cross-checks
FMPVerified financials
The method Fact-pinned
Sources

Regulators, registries, audited filings.

Verification

Figures pinned to FMP & ClinicalTrials.gov under strict null-handling.

Measurement

Daily 3-axis sentiment, forecast direction & magnitude.

Delivery

Calendar, alerts, briefs, analyst-authored reports.

Real-time intelligence News every few hours · sentiment daily

We track the market's pulse around the clock.

Every panel below is a working miniature of the platform — the same tools you get in your account, at reading size.

01 See it coming
F2 · CAL Calendar & alerts Sample
CHMP · ZYRN ALERT SET · T−3 DAYS

Every dated event, filterable by market, phase, and event type — with alerts before the tape wakes up.

Open the calendar →
F3 · BRF Morning brief Sample
WATCHLIST BRIEF · EVERY MORNING
HXPR  P3 readout Wed  ▼ watch
QVLT  PDUFA Mon  ▲ fcst +12–18%
NMBT  8-K filed  — noted

Your watchlist, briefed every morning before the open.

See plans →
02 Judge the move before the tape does
F4 · SNT Sentiment engine Sample
FINANCIAL 7.2
TECHNOLOGICAL 8.4
REGULATORY 5.1

Scores sentiment 0–10 across three independent dimensions — Financial, Technological and Regulatory — then tracks the divergence vs price.

Browse companies →
F5 · FCT Impact forecasts Sample
HXPR · P3 READOUT
▼ DOWNSIDE · −10–16%
CONFIDENCE 6/10

A direction call with confidence on every catalyst — and our record on calls like this is public.

Inspect the record →
F6 · AIB On-demand AI briefs Sample
BRIEF · GENERATED IN MINUTES
Cash runway to H2-27 [1]
Lead asset: Ph III enrolling [2]
Insider buys last qtr [3]

Any ticker, briefed on demand — every claim carries a live citation you can click and check. 14,750+ generated.

Generate a brief →
03 Follow the money
F7 · WHL Whale tracker Sample
FUND A · 13F+412k sh
FUND B · 13F−80k sh
CFO · FORM 4BUY · OPEN MKT
CONVICTION 8/10

13F institutional positions and Form 4 insider flow, conviction-scored per ticker.

Open whale tracker →
F8 · SIM The open book Sample
PAPER-TRADED · MIRRORED ON TRADING 212

We paper-trade our own signals in the open — wins and losses, on the record.

See the open book →
F9 · CMT Community consensus Sample
BULL 68% MEDIAN TARGET €24.50 BEAR 32%

Member bull/bear calls with target prices, scored into a consensus per ticker.

Join the forum →
The flagship report Analyst-authored · AI-accelerated
CV · DEEP-DIVE P. 1/14
Company Analysis
& Catalyst Outlook
THESIS · FINANCIALS · PIPELINE · CATALYSTS · RISKS

Every figure in this report is pinned to verified FMP financials or ClinicalTrials.gov2. A number is sourced, or it is blank — nothing in between. The pipeline table is cross-checked against the registry per protocol3

Authored by an analyst · reviewed before publication. 17–25 SOURCES CITED

Illustrative page — the format of a published deep-dive.

AI does the digging.
You place the trade.

The flagship institutional deep-dives are AI-assisted and analyst-authored: our analysts write every report in a frontier-model workbench, grounded in verified FMP financials and cross-checked against ClinicalTrials.gov. 12–15 pages, 17–25 cited sources each — and a fact-pinned model that can read the numbers but never invent them.

DEPTH12–15 pages
SOURCING17–25 citations
NUMBERSFMP-verified, fact-pinned
PIPELINERegistry cross-checked
REVIEWHuman, before publication

Source counts are per published report; every citation is listed inside the report itself. Pipeline status diffed against ClinicalTrials.gov per protocol.

Track record Published in full

Anyone can claim an AI is accurate.
We score it.

Every impact forecast we make is logged before the event and graded against the realized move after it — no retroactive forecasts, no quiet deletions. Most research products hope you never check. We built the page for you to check.

F5 · ACC Forecast ledger Sample format
EventForecastRealizedGrade
CHMP · QVLT ▲ +6–9% +7.4% ● HIT
PDUFA · ZYRN ▲ +10–16% −3.4% ✗ MISS
P3 · HXPR ▼ −10–16% −13.9% ● HIT
Illustrative format · forecasts are graded on the realized post-event direction · the live, unedited record — hits and misses — is on the accuracy page.

Forecasts are scored automatically against realized post-event moves; the running record is published in full, including the unflattering parts.

Pricing EUR · VAT inclusive

Simple, transparent pricing.

Annual billing is two months free. The Free tier is always free — sign up to get started, no card needed.

2 months free on annual
Free
€0

Try the platform · no card needed

  • AI company briefs (no deep-dive PDFs)
  • Basic sentiment & news feed
  • Catalyst calendar (view)
  • Capped watchlist
Investor
€19 / mo

or €190/yr · for serious investors

  • 5 deep-dive reports/month
  • Full sentiment history
  • Catalyst calendar + alerts
  • Impact Forecasts: direction + score on every catalyst
  • Unlimited watchlist & community access
Most popular
Pro
€99 / mo

or €990/yr · prosumers & small funds

  • Everything in Investor · 20 reports/month
  • Full Impact Forecast breakdowns + live accuracy stats
  • Whale Tracker (13F + insider flows)
  • Simulated portfolio bot + Trading 212 mirror
  • Data export & priority report generation
Institutional
Custom

annual · funds, IR & data teams

  • Everything in Pro
  • Catalyst & whale data feed / API
  • B2B seats
  • SLA & priority support
Contact us

Cancel anytime from your profile. Prices in EUR, inclusive of any applicable VAT. The Free tier needs no card.

Stay updated Product updates

Get product updates

Get notified about new reports, features and platform updates. No card. Unsubscribe anytime.

We store your address to send product updates — nothing else. Unsubscribe with one click.

Get started Free tier · no card required

Ready to outperform?

Create your free account for verified-data biotech research, built for serious European investors.

See pricing

Free tier available · No card required · Cancel anytime

Sources: SEC EDGAR · FDA · EMA CHMP · EU CTIS · ClinicalTrials.gov · FMP. Panels marked Sample show illustrative data in the product's format; figures with a live dot update from the platform. Catalyst Ventures is a research platform, not investment advice.